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Introduction: Hepatic encephalopathy (HE) is a serious neurological complication of acute or chronic liver disease (ALF, CLD), which is 
characterized by an array of cognitive and motor deficits leading to altered mental status, coma and death [1-3]. It is generally accepted that ammonia 
is a neurotoxin implicated in the pathogenesis of HE and that astrocytes represent the principal target due to the unique astrocytic expression of 
glutamine synthetase, which synthesizes glutamine (Gln) from glutamate (Glu) and ammonia [1,3]. The pathogenic mechanisms leading to astrocytes 
swelling and brain edema are complex, and sometimes controversial (amino acids disturbances; alterations in neurotransmission; cerebral energy 
deficit; alteration of oxidative stress, mitochondrial permeability transition; impairment of axonal and dendritic growth during brain development; 
signaling transduction pathways; alterations in channels and transporters activity) [1,3,4].  
Previous studies on CLD in humans were performed at low Bo and only few metabolites were reported (increase of Gln+Glu, and sometimes 
decrease in brain osmolytes (Ins, tCho)). Bile duct ligation (BDL) in rats is a frequently used animal model in CLD [5-6]. From our knowledge, only 
one previous in vivo study imaged longitudinally brain metabolism in a BDL rat model. They reported that the continuous increase of Gln can be 
compensated by a continuous decrease of other osmolytes with minimal brain edema and with no regional difference in Gln increase [6].1H MRS 
performed at high magnetic field and short echo time (TE) allows the measurement of about 20 brain metabolites. In this context, the aim of the 
present study was to asses in vivo and longitudinally several pathogenic 
mechanisms involved in HE (i.e. osmoregulation, neurotransmitter metabolism, 
oxidative stress, energy dysfunction, cell swelling) using 1H MRS and histology. 
Methods:  
Experiments were performed on a 9.4T system (Varian/Magnex Scientific) using a 
home-built 14 mm diameter quadrature 1H coil as a transceiver. Eight Wistar rats 
(300-350g) were bile duct ligated (BDL) [7] and scanned longitudinaly before and 
after BDL for 8 week (once per week). The ultra-short-echo time SPECIAL 
spectroscopy sequence (TE=2.8ms, TR=4s, 160 scans) [8] was used to localize a 
VOI of 2×2.8×2mm3 in the hippocampus. First and second order shims were 
adjusted using FASTMAP (linewidth of 9-12Hz). Concentrations of metabolites 
were calculated by LCModel using water as internal reference. Histological 
assessment of brain tissue was performed 8 weeks after ligation by 
immunofluorescence against the astrocytic marker glial fibrillary acidic protein 
(GFAP). 
Results and Discussion: 
Fig. 1 shows typical spectra acquired in the hippocampus of BDL rats before and 8 
weeks after ligation. In the present study we focused on the hippocampus due to its 
role in memory (a neurologic symptom in HE). 1H spectra exhibited excellent SNR 
(between 22 to 25 for 10 min of acquisition) allowing easy separation of Gln from 
Glu. Notable differences in metabolite signals were apparent already from the spectra (i.e. increase Gln, decrease Ins, Tau).  
The neurochemical profile (mean ± SEM) measured before and 4, 6, 8 weeks after BDL is shown in Fig 2A. Gln started to increase already at 1 week 
after BDL and continued to increase over time (more than 200% at 8 weeks). As a compensatory effect for the osmotic imbalance created by the Gln 
increase, other brain osmolytes started to decrease: Ins being the first one (~ 35%), followed by Tau and tCho with ~ 20 and 40%, respectively. Cr 
showed a trend of decrease over time reaching 
~20% at 8 weeks. Cr is a metabolite involved in 
energy metabolism but recently its involvement in 
osmoregulation and neuroprotection was reported 
[3]. Among the brain neurotransmitters, Glu, Asp 
and GABA were decrease over time (~15-30%, Fig 
2A). We also noticed a trend of decrease of Asc and 
GSH (~15%) which are considered to be important 
brain antioxidants. This might be due to the 
induction of oxidative stress by ammonia [1,3-5]. 
Even though the sum of the main brain osmolytes 
(Gln, Ins, tCho, Tau) was constant over time, 
meaning that to compensate for the Gln increase 
these metabolites decreased proportionately, 
astrocytes swelling was still noticeable as shown 
by GFAP (Fig 2B) and in agreement with brain edema measured by DTI [6].  
In conclusion, we characterized for the first time the in vivo and longitudinal progression of HE in a model of CLD using 1H MRS and histology. 
We were able to monitor changes in the brain osmolytes, neurotransmitters, antioxidants and cell swelling, something never previously assessed in 
such details in vivo in CLD. The use of in vivo longitudinal MRS and MRI measurements is mandatory promising tool for the assessment of HE 
progression in liver disease, especially prior to the onset of irreversible symptoms. 
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Fig. 2:A) Neurochemical profile (mean ± SEM) in the hippocampus of BDL rats before (0 week), and 
4, 6 and 8 weeks after ligation. For visibility reasons only these time points are shown; B) Astrocytes 
labeled by immunofluorescence against the GFAP protein; 16 µm thick cryosections of brain of 
control and BDL adult rats. Typical swelled astrocytes (double arrows), as compared to the normal 
ones (simple arrows) illustrated for the control rats.  
Fig. 1: In vivo brain spectra acquired in a rat model of CLD at 
9.4T. From top to bottom spectrum acquired before BDL and 8 
weeks after BDL. 
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